First-In-Human Study of OTO-413

A First-In-Human Study of OTO-413, an Intratympanic Sustained-Exposure Formulation of BDNF, for the Treatment of Speech-in-Noise Hearing Impairment Jeffery J. Anderson(1), James Robinson(1), Alice Blaj(1), Ines Hoffmann(1), Alan Foster(1), Justin Gull(2), Peter...

RCA Fall 2020 Newsletter

Research Centers of America (RCA), Broward County’s largest independent research site, is currently conducting COVID-19 vaccine trials, implemented under Operation Warp Speed (OWS). RCA is recruiting volunteers to participate in these clinical trials, working with the...
Translate »